Skip to main content

Advertisement

Table 3 Basic characteristics of participants in stage-2 study

From: Bioinformatics-based discovery of the urinary BBOX1 mRNA as a potential biomarker of diabetic kidney disease

  HC NA MA OA
Number 20 20 20 20
Age 49.7 ± 7.5 50.6 ± 15.3 50.1 ± 13.7 55.7 ± 14.0
Gender (male/female) 13/7 11/9 13/7 14/6
eGFR (ml/min/1.73 m2) 102.6 [95.0–114.6] 102.6 [77.1–115.0] 88.5 [79.2–138.8] 82.9 [32.8–123.8]*
ACR (mg/g) 10.1 [4.7–15.1] 12.0 [5.9–20.5] 78.4 [58.8–149.3]* 1503.0 [619.9–3743.0]*
Glu (mmol/L) 4.9 [4.3–5.2] 8.6 [7.0–11.1]* 10.1 [7.5–12.7]* 12.3 [7.5–15.0]*
HbA1c (%) 4.9 [4.7–5.2] 8.3 [7.0–10.2]* 8.5 [6.8–9.3]* 9.1 [8.2–11.1]*
SBP (mmHg) 116.5 ± 9.5 123.2 ± 10.6 135.4 ± 12.3* 145.5 ± 18.6*
DBP (mmHg) 74.3 ± 5.8 80.2 ± 7.3 82.5 ± 10.1* 85.5 ± 7.8*
Urinary NAG/Cr (U/mol) 0.48 ± 0.14 0.69 ± 0.27 1.17 ± 0.44* 1.93 ± 0.53*
  1. p < 0.05 compared with HCs